BOPA member publication on the impact of inter-cycle treatment delays on mortality in early-stage breast cancer

We would like to share a recent BOPA member publication

Pinkie Chambers et al. The impact of inter-cycle treatment delays on 5-year all-cause mortality in early-stage breast cancer: A retrospective cohort study. European Journal of cancer. Aug 2024. https://doi.org/10.1016/j.ejca.2024.114301.

 

The impact of inter-cycle treatment delays on 5-year all-cause mortality in early-stage breast cancer: A retrospective cohort study – ScienceDirect

Latest News

By BOPA on 23rd July 2025

Third Annual Cancer Associated Thrombosis Summit: North of England

The NEONC CAT conference returns this year on the 8th of November, in Hull. As the UK’s only dedicated cancer associated thrombosis (CAT) conference, it presents a unique opportunity for…

Read article
By BOPA on 22nd July 2025

BOPA Questionnaire – Monitoring and Treatments for Immune-Related Myocarditis

The BOPA Immunotherapy Specialist Interest Group invites all BOPA members to complete this survey. This builds on our previous work exploring the known disparity across the UK with regards to…

Read article
By BOPA on 22nd July 2025

BOPA Member on the current state and future trajectory of pharmacy in cancer services

As president of the International Society of Oncology Pharmacy Practitioners and co-chair of the UK SACT Board, BOPA Member Netty Cracknell is championing the role of oncology pharmacy in delivering…

Read article
By BOPA E&T Subcommittee on 22nd July 2025

BOPA E&T Webinar: Utilizing AI to assess aseptic technique

Wednesday 30th July 2025 at 19:00 BST   Click HERE to register   The BOPA Education and Training Subcommittee would like to invite you to the E&T Webinar: Utilizing AI…

Read article